Astrana Health, Inc. (NASDAQ:ASTH)
| Market Cap | $1.43B+27.9% |
| Revenue (ttm) | $3.91B+35.1% |
| Net Income | $53.13M+457.1% |
| EPS | $1.07+441.8% |
| Shares Out | 49.60M |
| PE Ratio | 26.76 |
| Forward PE | 15.73 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 440,987 |
| Open | $28.34 |
| Previous Close | $28.68 |
| Day's Range | $28.34 - $29.75 |
| 52-Week Range | $18.08 - $51.60 |
| Beta | 0.91 |
| Analysts | Buy |
| Price Target | $56.50(+95.50%) |
| Earnings Date | Mar 1, 2027 |
About ASTH
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
Analyst consensus
2 firms rating ASTH in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Mar 1, 2027Earnings report
$ASTH stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in ASTH holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ASTH's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ASTH Estimated quarterly lobbying spending
Source: U.S. Senate LDA
ASTH Revenue by Segment
| Medicare | $627.48M | 61.30% |
| Medicaid | $268.69M | 26.25% |
| Commercial | $85.71M | 8.37% |
| Other third parties | $41.74M | 4.08% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New ASTH patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ASTH from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ASTH
| IJRiShares Core S&P Small-Cap ETF | $73.34M |
| VTIVanguard Morningstar Total Stock Market ETF | $40.80M |
| VBVanguard Morningstar Small-Cap ETF | $36.46M |
| IWMiShares Russell 2000 ETF | $35.40M |
| VBKVanguard Morningstar Small-Cap Growth ETF | $20.44M |
| VXFVanguard Extended Market ETF | $17.44M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from ASTH’s recent data — informational, not investment advice
What’s Behind the Score
News check: Mixed coverage with margin expansion offset by Medicaid headwinds; earnings guidance update signals management recalibration without clear directional consensus.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| XHS | State Street SPDR S&P Health Care Services ETF | 1.36% |
| HEAL | Global X HealthTech ETF | 1.00% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.58% |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.27% |
| VIOV | Vanguard S&P Small-Cap 600 Value ETF | 0.17% |
| IHF | iShares U.S. Healthcare Providers ETF | 0.16% |
| IJS | iShares S&P Small-Cap 600 Value ETF | 0.15% |
| SLYV | State Street SPDR S&P 600 Small Cap Value ETF | 0.15% |
| AFSM | First Trust Active Factor Small Cap ETF | 0.13% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.12% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.11% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.11% |
Weight is the stock’s share of each fund’s holdings.
